© 2009 The Serbian Association of Dermatovenereologists 77 Clinical diagnosis requires the presence of at least 2 of the following 7 diagnostic criteria: 1. Six or more

Short stature and growth hormone deficiency: unexpected manifestations of McCune-Albright syndrome1Pina Rivera Y, et al. BMJ Case Rep 2018. doi:10.1136/bcr-2018-225709

Legius syndromeLegius syndrome Description Legius syndrome is a condition characterized by changes in skin coloring (pigmentation). Almost all affected individuals have multiple

Legius syndrome: case report and review of literatureBenelli et al. Italian Journal of Pediatrics (2015) 41:8 DOI 10.1186/s13052-015-0115-9 CASE REPORT Open Access Legius

Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFRGraphical Abstract d The NF1(GRD) uses

Update on NeurofibromatosisClassification • In 1882 Friedrich Daniel von Recklinghausen, a pathologist, outlines the features of NF • In 1982 V. Riccardi proposed

Revision of Diagnostic Criteria for Neurofibromatosis Gareth Evans, MD, St. Mary’s Hospital/University of Manchester, UK Susan Huson, MD, Consultant Geneticist, UK

ANPGM_111-v2-Neurofibomatose 1-LegiusRéférence : ANPGM_ 111 Numéro de version : 2.0 Page : 1/10 Date de Création : 30/12/2010 Date de validation

FEP Medical Policy Manual FEP 2.04.137 Genetic Testing for Neurofibromatosis Effective Policy Date: April 1, 2021 Original Policy Date: April 2018 Related Policies: None

Neurofibromatosis type 1Neurofibromatosis type 1 Description Neurofibromatosis type 1 is a condition characterized by changes in skin coloring ( pigmentation) and the growth